☆ 4.7 Article

Virtual screening and structure-activity relationship study of novel BTK inhibitors in Traditional Chinese Medicine for the treatment of rheumatoid arthritis

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors

Xiaoyun Lu et al.

Summary: Small molecule covalent kinase inhibitors (CKIs) have advantages for sustained target inhibition and high selectivity, with major medicinal chemistry strategies involving the addition of a warhead to a reversible lead/inhibitor scaffold to generate CKIs, while also facing challenges in drug discovery in this area.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis

Ning Wu et al.

Summary: This study investigated the molecular mechanisms of Compound Sidaxue (SX) in treating rheumatoid arthritis (RA) using network pharmacology and in vivo experiments. The active components and key targets of SX were identified using network pharmacology, and their effects were validated in a rat model of RA. The results suggest that SX can alleviate RA symptoms by modulating the VEGF/ PI3K/AKT signaling pathway, TNF-alpha signaling pathway, and IL/NF-kappa B signaling pathway.

DRUG DESIGN DEVELOPMENT AND THERAPY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Software update: The ORCA program system-Version 5.0

Frank Neese

Summary: The latest version 5.0 of the ORCA quantum chemistry program suite represents a significant improvement in performance, numerical robustness, functionality, and user friendliness.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2022)

添加到收藏夹

Article Immunology

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors

Vikas Kumar et al.

Summary: This study aimed to identify potential inhibitors against SYK with higher affinity, selectivity, and drug-like properties compared to existing inhibitors. Through the use of 3D-QSAR modeling, molecular docking, and molecular dynamics simulations, multiple potential inhibitors were screened and their binding modes were analyzed. The study found that these compounds formed important interactions with key residues of SYK.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

A Novel Drug Combination of Mangiferin and Cinnamic Acid Alleviates Rheumatoid Arthritis by Inhibiting TLR4/NFκB/NLRP3 Activation-Induced Pyroptosis

Weijie Li et al.

Summary: This study identified bioactive compounds and mechanisms of Baihu-Guizhi decoction (BHGZD) through multiple techniques, revealing its effectiveness in treating rheumatoid arthritis by inhibiting TLR4/PI3K/AKT/NF kappa B/NLRP3 signaling-mediated pyroptosis.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Exploration of N-Arylsulfonyl-indole-2-carboxamide Derivatives as Novel Fructose-1,6-bisphosphatase Inhibitors by Molecular Simulation

Yilan Zhao et al.

Summary: A series of potential fructose-1,6-bisphosphatase (FBPase) inhibitors for type II diabetes mellitus treatment were identified through computational modeling. The study provided important insights into the development of novel FBPase inhibitors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking

Samia A. Elseginy et al.

Summary: This research identified a novel compound that inhibits microtubule protein and shows potential anticancer activity. It suppresses cancer cell proliferation, induces cell cycle arrest and apoptosis, and has low toxicity. The compound blocks tubulin polymerization and activates caspase 9, leading to apoptosis.

RSC MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pharmacore maping based on docking, ADME/toxicity, virtual screening on 3,5-dimethyl-1,3,4-hexanetriol and dodecanoic acid derivates for anticancer inhibitors

Palanisamy Prakash et al.

Summary: This study analyzed compounds isolated from Decalepis hamiltonii using molecular docking and virtual screening, identifying a number of potential anti-cancer drug molecules that meet ADME and toxicity parameters. The research may provide clues for discovering novel drug inhibitors with similar activity for cancer properties.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

Sk. Abdul Amin et al.

Summary: This study focuses on the potential drug discovery for COVID-19 caused by SARS-CoV-2, specifically targeting viral protease enzymes. Challenges in developing effective protease inhibitors are discussed, with emphasis on the importance of oral delivery and optimizing pharmacokinetic properties for drug development. Combining adequate pharmacokinetic properties with coronavirus protease activity and selectivity may offer potential drug candidates in the future.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors

Chunhua Ma et al.

Summary: The discovery of novel BTK inhibitors has shown promising results in treating B-cell malignancies by suppressing the aberrant activation of BTK, leading to a paradigm shift in therapy. The potential of these inhibitors as a new therapeutic option for B-cell lymphomas is supported by their impressive selectivity, favorable pharmacokinetic properties, and robust antitumor efficacy in vivo. Furthermore, the use of 1-amino-1H-imidazole-5-carboxamide as a hinge binder in kinase inhibitors is a groundbreaking development, expanding the chemical diversity of kinase inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Investigating natural compounds against oncogenic RET tyrosine kinase using pharmacoinformatic approaches for cancer therapeutics

Shraddha Parate et al.

Summary: A new RET inhibitor was developed to combat drug resistance in specific mutated kinase variants, with potential active drug-like compounds identified through screening of natural products. The study demonstrated the potential of these compounds as potent RET inhibitors and provided insights for drug optimization targeting aberrant activation of RET signaling, specifically the gate-keeper residue Val804 mutation.

RSC ADVANCES (2021)

添加到收藏夹

Review Cell Biology

Management of Rheumatoid Arthritis: An Overview

Andrei-Flavius Radu et al.

Summary: Rheumatoid arthritis is a multifactorial autoimmune disease with unknown etiology, requiring a multidisciplinary approach for effective management. Recent medical advances have improved the clinical status of RA patients, with disease-modifying anti-rheumatic drugs being a key treatment option.

CELLS (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential

Dan-na Huang et al.

Summary: The study recaps the potential therapeutic effects and mechanisms of action of berberine in treating rheumatoid arthritis, as well as discusses its modulation of gut microbiota during RA. Berberine may be a promising lead drug with multi-functional activities for the therapeutic strategy of RA.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Stefan F. H. Neys et al.

Summary: Systemic autoimmune disorders are complex chronic diseases involving diverse immune cells, with many patients responding poorly to current therapies. The development of more specific and tolerable treatments is needed. BTK has emerged as an interesting therapeutic target due to its involvement in key signaling pathways driving autoimmunity, with second-generation BTK inhibitors showing promise in clinical trials for autoimmune diseases.

DRUGS (2021)

添加到收藏夹

Review Immunology

Bruton's Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis

Laura C. Arneson et al.

Summary: BTK inhibitors, as an emerging class of drugs, have shown promise in treating various autoimmune diseases, including rheumatoid arthritis, but their efficacy in human clinical trials remains inconclusive. Current research focuses on the therapeutic effects of BTK inhibitors on RA and potential directions for future studies.

IMMUNOTARGETS AND THERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing

Jian Liu et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Virtual Screening and Bioactivity Evaluation of Novel Androgen Receptor Antagonists From Anti-PCa Traditional Chinese Medicine Prescriptions

Wenya Han et al.

FRONTIERS IN CHEMISTRY (2020)

添加到收藏夹

Article Immunology

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Philipp Haselmayer et al.

JOURNAL OF IMMUNOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors

Aditya Sharma et al.

JOURNAL OF MOLECULAR MODELING (2019)

添加到收藏夹

Article Integrative & Complementary Medicine

Effects of Qingluo Tongbi Decoction on Gut Flora of Rats with Adjuvant-Induced Arthritis and the Underlying Mechanism

Yan Huang et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases

Richard D. Caldwell et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Editorial Material Medicine, General & Internal

Rheumatoid Arthritis

Jeffrey A. Sparks

ANNALS OF INTERNAL MEDICINE (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents

Shumaila Tasneem et al.

PHARMACOLOGICAL RESEARCH (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Development of Bruton's Tyrosine Kinase Inhibitors for Rheumatoid Arthritis

Jiahui Lv et al.

CURRENT MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Combined pharmacophore, virtual screening and molecular dynamics studies to identify Bruton's tyrosine kinase inhibitors

Seethalakshmi Sakthivel et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)

添加到收藏夹

Article Plant Sciences

Predicting tyrosinase inhibition by 3D QSAR pharmacophore models and designing potential tyrosinase inhibitors from Traditional Chinese medicine database

Hongwei Gao

PHYTOMEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Novel treatment strategies in rheumatoid arthritis

Gerd R. Burmester et al.

LANCET (2017)

添加到收藏夹

Article Oncology

DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway

Jianxin Ye et al.

MOLECULAR ONCOLOGY (2017)

添加到收藏夹

Review Medicine, General & Internal

Rheumatoid arthritis

Josef S. Smolen et al.

LANCET (2016)

添加到收藏夹

Article Environmental Sciences

3D-QSAR studies on the toxicity of substituted benzenes to Tetrahymena pyriformis: CoMFA, CoMSIA and VolSurf approaches

M. Salahinejad et al.

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2014)

添加到收藏夹

Article Rheumatology

Disability in rheumatoid arthritis in the era of biological treatments

Eswar Krishnan et al.

ANNALS OF THE RHEUMATIC DISEASES (2012)

添加到收藏夹

Article Oncology

Diabetes and breast cancer risk: a meta-analysis

P. Boyle et al.

BRITISH JOURNAL OF CANCER (2012)

添加到收藏夹

Article Chemistry, Multidisciplinary

Multiwfn: A multifunctional wavefunction analyzer

Tian Lu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)

添加到收藏夹

Article Chemistry, Medicinal

Bruton's Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies

Yan Lou et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

添加到收藏夹

Article Medicine, General & Internal

Rheumatoid arthritis

David L. Scott et al.

LANCET (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Elucidating Drug-Enzyme Interactions and Their Structural Basis for Improving the Affinity and Potency of Isoniazid and Its Derivatives Based on Computer Modeling Approaches

Auradee Punkvang et al.

MOLECULES (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases

Douglas J. Marcotte et al.

PROTEIN SCIENCE (2010)

添加到收藏夹

Article Chemistry, Medicinal

Conformational sampling of druglike molecules with MOE and catalyst: Implications for pharmacophore modeling and virtual screening

I-Jen Chen et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

The value of natural products to future pharmaceutical discovery

Dwight D. Baker et al.

NATURAL PRODUCT REPORTS (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.